πŸ‡ΊπŸ‡Έ FDA
Patent

US 9493484

Heterocyclic compound and use thereof

granted A61PA61P25/18A61P25/24

Quick answer

US patent 9493484 (Heterocyclic compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P25/18, A61P25/24, A61P25/28, A61P43/00